EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5

Gabriel Diem, Michael Jäger, Stefanie Dichtl iD, Angelika Bauer, Cornelia Lass-Flörl iD, Markus Reindl, Doris Wilflingseder iD, Wilfried Posch iD

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.05163-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Gabriel Diem und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, NINR NIH HHS, Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rising incidences of breakthrough infections caused by SARS-CoV-2 Omicron BA.4/5 have been observed. Although various studies were conducted investigating neutralizing antibodies in sera, mucosal immunity was barely evaluated. Here, we investigated mucosal immunity, since the presence of neutralizing antibodies at mucosal entry sites plays a fundamental role in disease limitation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansBNT162 VaccineCOVID-19 Vaccines2019-nCoV Vaccine mRNA-1273Cohort StudiesConvalescenceVaccinationAntibodies, NeutralizingAntibodies, ViralBreakthrough InfectionsImmunoglobulin A

Stichwörter der Autor:innen

COVID-19 vaccinesOmicron BA.4/5SARS-CoV-2adaptive immunityneutralizing antibodiessystemic/mucosal immunity

Substanzen

BNT162 VaccineCOVID-19 Vaccines2019-nCoV Vaccine mRNA-1273Antibodies, NeutralizingAntibodies, ViralImmunoglobulin A

Autor:innen und Institutionen

  • Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

ORCID-Profile: Stefanie Dichtl, Cornelia Lass-Flörl, Doris Wilflingseder, Wilfried Posch

Förderung

  • Austrian Science Fund FWF
  • NINR NIH HHS
  • Austrian Science Fund

Zitieren

APA

Diem, G., Jäger, M., Dichtl, S., Bauer, A., Lass-Flörl, C., Reindl, M., Wilflingseder, D., & Posch, W. (2023). Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5. Microbiology Spectrum. https://doi.org/10.1128/spectrum.05163-22

Vancouver

Diem G, Jäger M, Dichtl S, Bauer A, Lass-Flörl C, Reindl M, et al. Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5. Microbiology Spectrum. 2023. doi:10.1128/spectrum.05163-22

BibTeX
@article{Diem2023,
  author = {Diem, Gabriel and Jäger, Michael and Dichtl, Stefanie and Bauer, Angelika and Lass-Flörl, Cornelia and Reindl, Markus and Wilflingseder, Doris and Posch, Wilfried},
  title = {Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.05163-22}
}
Kostenlos starten →